Home › Funds › Lion Point Capital, LP › GERN
Lion Point Capital, LP position in GERN
GERON CORP · Health Care
Lion Point Capital, LP reported holding 578,000 shares of GERN (GERON CORP) in its Q2 2026 13F filing — a position valued at US$740K, representing 3.54% of its reported portfolio and ranking #11 among its reported holdings. Lion Point Capital, LP has disclosed GERN holdings in 10 of the last 10 reported quarters, going back to Q1 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Lion Point Capital, LP's GERN position evolved
Lion Point Capital, LP first disclosed a stake in GERN in Q1 2024 at 600,000 shares (US$2.0M). The position peaked in Q3 2024 at 630,000 shares, worth US$2.9M. Across 10 filings, Lion Point Capital, LP increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 6 time(s). The most recent filing (Q2 2026) shows 578,000 shares valued at US$740K.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2024 | 600.00K | $1.98M | New |
| Q2 2024 | 630.00K | $2.67M | Add |
| Q3 2024 | 630.00K | $2.86M | Hold |
| Q4 2024 | 500.00K | $1.77M | Reduce |
| Q1 2025 | 500.00K | $795.00K | Hold |
| Q2 2025 | 500.00K | $705.00K | Hold |
| Q3 2025 | 500.00K | $685.00K | Hold |
| Q4 2025 | 578.00K | $762.96K | Add |
| Q1 2026 | 578.00K | $861.22K | Hold |
| Q2 2026 | 578.00K | $739.84K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GERN and 13F data
GERN (GERON CORP) is a Health Care company. 19 other funds we track also report a position in GERN — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$54.8M), Soleus Capital Management, L.P. (US$54.8M), Eversept Partners, LP (US$24.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GERN
- RA CAPITAL MANAGEMENT, L.P. 42.81M sh · $54.80M · Q2 2026
- Soleus Capital Management, L.P. 42.81M sh · $54.80M · Q2 2026
- Eversept Partners, LP 18.72M sh · $23.96M · Q2 2026
- Nantahala Capital Management, LLC 12.22M sh · $15.65M · Q2 2026
- Vivo Capital, LLC 8.67M sh · $11.10M · Q2 2026
- Kynam Capital Management, LP 6.84M sh · $8.75M · Q2 2026
More on Lion Point Capital, LP
FAQ
How long has Lion Point Capital, LP held GERN?
Lion Point Capital, LP has disclosed GERN holdings in 10 of the last 10 reported quarters, going back to Q1 2024.
What is Lion Point Capital, LP's current position in GERN?
As of Q2 2026, Lion Point Capital, LP holds 578.00K shares of GERN (GERON CORP), valued at $739.84K, representing 3.54% of its reported portfolio and ranking #11.
Has Lion Point Capital, LP been buying or selling GERN?
In the latest 13F filing (Q2 2026), Lion Point Capital, LP held unchanged its position in GERN. The position peaked in Q3 2024 at 630.00K shares.
Which other funds hold GERN?
Other major institutional holders of GERN include RA CAPITAL MANAGEMENT, L.P., Soleus Capital Management, L.P., Eversept Partners, LP, among 19 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.